Tecentriq 1 200 mg concentrate for solution for infusion, Avastin 25 mg/ml concentrate for solution for infusion. clinical trials

A Randomized Phase III Trial of Platinum Chemotherapy plus Paclitaxel with Bevacizumab and Atezolizumab versus Platinum Chemotherapy plus Paclitaxel and Bevacizumab in Metastatic (stage IVB), Persistent, or Recurrent Carcinoma of the Cervix (BEATcc )

This study is testing new treatments for advanced cervical cancer. It compares adding two medicines, Teccentriq and Avastin, to standard chemotherapy, against chemotherapy with just Avastin. Doctors want to see if this combination helps patients live longer and stops the cancer from growing.